MannKind Corp (MNKD)

S&P 500: 1,300.68
Change: 1.48%

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

Recs

Avatar taxguydoug (69.36) Submitted: 6/06/07 2:50 PM : Start Price: $10.42 MNKD Score: -48.92

Bill Miller is bullish, that's enough for me.

Featured Broker Partners